Article

Central Airway Collapse Triggers Worse Events, Study Finds

Author(s):

Expiratory central airway collapse (ECAC) leads to a worse respiratory quality of life, Alabama researchers found.

pulmonology

A study has found that expiratory central airway collapse (ECAC) leads to a worse respiratory quality of life. The study was published in the Journal of the American Medical Association on February 2, 2016, and was conducted by Surya P. Bhatt, MD, of the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Alabama Birmingham, and colleagues.

The researchers began with the aim of discovering whether or not ECAC leads to respiratory morbidity in smokers, regardless of any underlying lung disease. They used computed tomography (CT) scans to determine if ECAC existed, and St. George’s Questionnaire (SGRQ) to determine the baseline respiratory quality of life for 8820 participants, some of whom had chronic obstructive lung diseases, and some who were not diagnosed with the condition.

Current and former smokers were included in the study, and participants were aged between 45 and 80 years old. All participants had been part of the COPDGene study previously. There were 4667 men (56.7%), 5428 (66%) white people, 2792 African Americans (34%), and 4559 (51.7%) were current smokers. Additionally 3856 (43.7%) had been diagnosed with COPD. The researchers identified 443 cases of ECAC and found that there were more cases of ECAC among the participants who had been diagnosed with COPD.

This cohort of study participants was considered high risk because it consisted of current and former smokers, and according to the researchers “the prevalence of ECAC was 5%, and presence of ECAC was associated with worse respiratory quality of life.” Past studies were limited by small sample sizes, as well as selection bias.

The authors of this study report, “We found that ECAC was associated with increased incidence of acute respiratory events on a follow-up in participants without COPD and with increased incidence of severe exacerbations in those with airflow obstruction.” Because this is a new finding, the researchers recommend that future studies should be done to find out if ECAC is part of a continuum of inflammation or if it causes respiratory decompensation.

Related Videos
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Use of Vaping Among Students, Conversations About Vaccines
Pavel Strnad, MD | Credit: RWTH Aachen
Janelle Bludhorn, MS, PA-C: How Common Medications Are Impacted by Extreme Heat
© 2024 MJH Life Sciences

All rights reserved.